Iria
Vázquez Urio

Investigadora fins a 2023

Foto de Iria

Foto de Hospital Universitario Reina Sofia

Hospital Universitario Reina Sofia

Córdoba, España

Publicacions en col·laboració amb investigadors/es de Hospital Universitario Reina Sofia (6)

2022

Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study
Cancers, Vol. 14, Núm. 23

2006

ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia
Oncogene, Vol. 25, Núm. 13, pp. 1862-1870
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia
International Journal of Cancer, Vol. 118, Núm. 8, pp. 1945-1953
Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter
British Journal of Haematology, Vol. 134, Núm. 2, pp. 137-144

2005

Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib
Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26
Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia [10]
Leukemia